These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3524835)

  • 1. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
    Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
    Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
    Knight WA; Drelichman A; Fabian C; Bukowski RM
    Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
    Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
    Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phase II and III studies of vindesine in children with leukemia and lymphoma].
    Ise T; Akabane T; Fujimoto T; Sakurai M; Taguchi N; Miyazaki T; Hattori M; Ito M; Masaoka T; Maekawa T
    Rinsho Ketsueki; 1986 Feb; 27(2):149-57. PubMed ID: 3522957
    [No Abstract]   [Full Text] [Related]  

  • 5. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
    Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
    Moore MR; Graham SD; Birch R; Irwin L
    Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
    Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA
    Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of chlorozotocin in leukemia and other hematologic malignancies.
    Pavlovsky S; Woolley PV; Garay G; Scaglione C; Hoth D; Schein PS
    Cancer Treat Rep; 1981; 65(11-12):1109-11. PubMed ID: 6457686
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
    Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
    Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
    Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
    Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
    Thongprasert S; Bosl GJ; Geller NL; Wittes RE
    Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
    Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
    Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma: MGBG new studies, compassionate use in earlier disease.
    Mascolini M
    AIDS Treat News; 1995 Dec; (no 237):4. PubMed ID: 11363077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations].
    Hanauske AR
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():68-70. PubMed ID: 8692122
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
    Levi JA; Wiernik PH
    Cancer Chemother Rep; 1975; 59(5):1043-5. PubMed ID: 54215
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of zinostatin in children with late-stage acute lymphocytic leukemia: a Pediatric Oncology Group Study.
    Sexauer C; Kim T; Nix W; Berry DH; Morgan S
    Cancer Treat Rep; 1981; 65(1-2):173-4. PubMed ID: 6452947
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of mitogauzone in malignant primary brain tumors.
    Feun LG; Yung WK; Stewart DJ; Savaraj N; Bodey GP
    Cancer Treat Rep; 1985 Mar; 69(3):329-30. PubMed ID: 3978660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Blume KG; Long GD; Negrin RS; Chao NJ; Kusnierz-Glaz C; Amylon MD
    Bone Marrow Transplant; 1994; 14 Suppl 4():S9-10. PubMed ID: 7728133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.